News
EQS-News: Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion
DGAP-News: Vita 34 präsentiert sich erstmals in neuer Größe im Rahmen der ordentlichen Hauptversammlung 2021
DGAP-News: Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021
EQS-News: Julie Tay neu zur Wahl in den Sonova Verwaltungsrat nominiert
EQS-News: Sonova nominates Julie Tay for election as a new member of the Board of Directors
DGAP-Adhoc: PAUL HARTMANN AG: PAUL HARTMANN AG (ISIN DE0007474041): Ergebnisprognose Geschäftsjahr 2022
EQS-News: Straumann Group Capital Markets Day 2021
DGAP-News: M1 Kliniken AG continues successful development in Q4 2021
DGAP-News: M1 Kliniken AG weiterhin erfolgreich im 4. Quartal 2021
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
DGAP-News: MicroVision Inc.: MicroVision to Participate in LiDAR Sensor Standards Consortium
DGAP-News: Eckert & Ziegler kooperiert mit University Health Network und CanProbe zur Anwendungserweiterung des Radiodiagnostikums PENTIXAFOR
DGAP-News: Eckert & Ziegler Partners with University Health Network and CanProbe to Advance PENTIXAFOR Imaging Diagnostic Tool for Wider Application
3 Oversold Stocks with Big RSI Rebound Potential
Everybody loves finding a bargain or getting a good deal, and it's no different when it comes to stocks. One of the most popular technical indicators for helping investors find these is the
Here’s Why Surgery Partners Could Be the Next Hot Takeover
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs. The company has a vast portfolio of
Top Stress-Free Stock Picks to Secure Your Portfolio This Fall
Investors often think of the start of autumn as a time of increased volatility for the market due to a phenomenon known as the "September Effect," a historically-verifiable trend in which the
New Book Reveals First Ever Neuroscience-Powered GenAI Tools Global Brands Are Using to Win Consumers
Written by Sensori.Ai CEO Dr. A.K. Pradeep, “Neuro AI: How to Win the Minds of Consumers Using Neuroscience-Powered Gen AI” leverages his success working with the biggest global brands to
Neues Buch enthüllt erstmals neurowissenschaftlich gestützte GenAI-Tools, die internationale Marken zur Kundengewinnung einsetzen
In seinem Buch „Neuro AI: How to Win the Minds of Consumers Using Neuroscience-Powered Gen AI“ teilt Sensori.Ai-CEO Dr. A.K. Pradeep die Erkenntnisse aus seiner erfolgreichen Zusammenarbeit
Medtronic Stock: Growth On Rise of the Cardiovascular Machines
Medtronic plc (NYSE: MDT) is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseases an aging population
Fed Rate Cuts on the Horizon: Why These 2 Stocks Stand to Benefit
The U.S. unemployment rate remains relatively low at 4.3%, although it is rising as employers hire at a slower pace than earlier in the year. The U.S. Bureau of Labor Statistics' early-September
Agilent Technologies Thrives From the Forever Chemicals Crackdown
Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics, and applied chemical markets. The company provides equipment systems, instruments, software
3 Stocks to Own if You Are Bearish on The Market
There are many reasons for the market to be bearish today, but the primary ones are the FOMC and the outlook for interest rates. The FOMC is set to cut rates this year, but the economic data isn’t
Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
Shares of medical device manufacturer Medtronic PLC (NYSE: MDT) are down about 35% from their highs of roughly three years ago, but promising results from the company's first quarter of fiscal
Clinical Trials to get Underway with Multiplo® Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada
Halifax, Nova Scotia, 13 August, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces it will conduct full clinical trials for its unique Multiplo® Complete Syphilis (TP/nTP) Antibody